Prostate Cancer

This study is for males age 18 years or older with confirmed prostate adenocarcinoma with an estimated life expectancy of 6 months or more based on the investigator’s judgement. Patients should have a baseline PSA greater than 5 ng/mL. Patient must also have had prior surgical castration or use of an agent for medical castration. Labs will be taken for adequate organ function and bone marrow function to determine participation in the study.